146 research outputs found
Portal Hypertension, Variceal Bleeding, and High Output Cardiac Failure Secondary to an Intrahepatic Arterioportal Fistula
Intrahepatic arterioportal fistulas (APF) are uncommon complications following hepatic trauma. Large
fistulas can result in portal hypertension and cardiovascular compromise. A 46-year-old patient is
described who presented with portal hypertension, variceal bleeding, and high output cardiac failure
due to a large intrahepatic APF. Surgical closure of the APF by hepatic resection successfully resolved
the portal hypertension, prevented further variceal hemorrhage, and restored normal cardiovascular
function
Tree Resin Flow Dynamics during an Experimentally Induced Attack by Ips avulsus, I. calligraphus, and I. grandicollis
The success of tree colonization by bark beetles depends on their ability to overcome host tree defenses, including resin exudation and toxic chemicals, which deter bark beetle colonization. Resin defenses during insect outbreaks are challenging to study in situ, as outbreaks are stochastic events that progress quickly and thus preclude the establishment of baseline observations of non-infested controls. We use synthetic aggregation pheromones to demonstrate that confined Ips bark beetle herbivory can be successfully initiated to provide opportunities for studying interactions between bark beetles and their hosts, including the dynamics of constitutive and induced resin exudation. In Pinus taeda L. plantations between 12 and 19 years old in North and South Carolina, U.S., trees were affixed with pheromone lures, monitored for evidence of bark beetle attacks, and resin samples were collected throughout the growing season. Baiting increased beetle herbivory to an extent sufficient to produce an induced resin response. Attacked trees exuded about three times more resin at some time than control trees. This supports previous work that demonstrated that information on constitutive resin dynamics alone provides an incomplete view of a host tree's resistance to bark beetle attack.Peer reviewe
On the Formation of Planetesimals via Secular Gravitational Instabilities with Turbulent Stirring
We study the gravitational instability (GI) of small solids in a gas disk as
a mechanism to form planetesimals. Dissipation from gas drag introduces secular
GI, which proceeds even when standard GI criteria for a critical density or
Toomre's predict stability. We include the stabilizing effects of turbulent
diffusion, which suppresses small scale GI. The radially wide rings that do
collapse contain up to Earth masses of solids. Subsequent
fragmentation of the ring (not modeled here) would produce a clan of chemically
homogenous planetesimals. Particle radial drift time scales (and, to a lesser
extent, disk lifetimes and sizes) restrict the viability of secular GI to disks
with weak turbulent diffusion, characterized by . Thus
midplane dead zones are a preferred environment. Large solids with radii
cm collapse most rapidly because they partially decouple from the
gas disk. Smaller solids, even below mm-sizes could collapse if
particle-driven turbulence is weakened by either localized pressure maxima or
super-Solar metallicity. Comparison with simulations that include particle
clumping by the streaming instability shows that our linear model underpredicts
rapid, small scale gravitational collapse. Thus the inclusion of more detailed
gas dynamics promotes the formation of planetesimals. We discuss relevant
constraints from Solar System and accretion disk observations.Comment: Accepted for publication in the Astrophysical Journal; 20 pages, 10
figure
Rapid planetesimal formation in turbulent circumstellar discs
The initial stages of planet formation in circumstellar gas discs proceed via
dust grains that collide and build up larger and larger bodies (Safronov 1969).
How this process continues from metre-sized boulders to kilometre-scale
planetesimals is a major unsolved problem (Dominik et al. 2007): boulders stick
together poorly (Benz 2000), and spiral into the protostar in a few hundred
orbits due to a head wind from the slower rotating gas (Weidenschilling 1977).
Gravitational collapse of the solid component has been suggested to overcome
this barrier (Safronov 1969, Goldreich & Ward 1973, Youdin & Shu 2002). Even
low levels of turbulence, however, inhibit sedimentation of solids to a
sufficiently dense midplane layer (Weidenschilling & Cuzzi 1993, Dominik et al.
2007), but turbulence must be present to explain observed gas accretion in
protostellar discs (Hartmann 1998). Here we report the discovery of efficient
gravitational collapse of boulders in locally overdense regions in the
midplane. The boulders concentrate initially in transient high pressures in the
turbulent gas (Johansen, Klahr, & Henning 2006), and these concentrations are
augmented a further order of magnitude by a streaming instability (Youdin &
Goodman 2005, Johansen, Henning, & Klahr 2006, Johansen & Youdin 2007) driven
by the relative flow of gas and solids. We find that gravitationally bound
clusters form with masses comparable to dwarf planets and containing a
distribution of boulder sizes. Gravitational collapse happens much faster than
radial drift, offering a possible path to planetesimal formation in accreting
circumstellar discs.Comment: To appear in Nature (30 August 2007 issue). 18 pages (in referee
mode), 3 figures. Supplementary Information can be found at 0708.389
Efficacy and safety of D,L-3-hydroxybutyrate (D,L-3-HB) treatment in multiple acyl-CoA dehydrogenase deficiency
PURPOSE: Multiple acyl-CoA dehydrogenase deficiency (MADD) is a life-threatening, ultrarare inborn error of metabolism. Case reports described successful D,L-3-hydroxybutyrate (D,L-3-HB) treatment in severely affected MADD patients, but systematic data on efficacy and safety is lacking.METHODS: A systematic literature review and an international, retrospective cohort study on clinical presentation, D,L-3-HB treatment method, and outcome in MADD(-like) patients.RESULTS: Our study summarizes 23 MADD(-like) patients, including 14 new cases. Median age at clinical onset was two months (interquartile range [IQR]: 8 months). Median age at starting D,L-3-HB was seven months (IQR: 4.5 years). D,L-3-HB doses ranged between 100 and 2600 mg/kg/day. Clinical improvement was reported in 16 patients (70%) for cardiomyopathy, leukodystrophy, liver symptoms, muscle symptoms, and/or respiratory failure. D,L-3-HB appeared not effective for neuropathy. Survival appeared longer upon D,L-3-HB compared with historical controls. Median time until first clinical improvement was one month, and ranged up to six months. Reported side effects included abdominal pain, constipation, dehydration, diarrhea, and vomiting/nausea. Median D,L-3-HB treatment duration was two years (IQR: 6 years). D,L-3-HB treatment was discontinued in 12 patients (52%).CONCLUSION: The strength of the current study is the international pooling of data demonstrating that D,L-3-HB treatment can be effective and safe in MADD(-like) patients.</p
Impact of early treatment with intravenous vasodilators and blood pressure reduction in acute heart failure
Objective Although vasodilators are used in acute heart failure (AHF) management, there have been no clear supportive evidence regarding their routine use. Recent European guidelines recommend systolic blood pressure (SBP) reduction in the range of 25% during the first few hours after diagnosis. This study aimed to examine clinical and prognostic significance of early treatment with intravenous vasodilators in relation to their subsequent SBP reduction in hospitalised AHF. Methods We performed post hoc analysis of 1670 consecutive patients enrolled in the Registry Focused on Very Early Presentation and Treatment in Emergency Department of Acute Heart Failure. Intravenous vasodilator use within 6 hours of hospital arrival and subsequent SBP changes were analysed. Outcomes were gauged by 1-year mortality and diuretic response (DR), defined as total urine output 6 hours posthospital arrival per 40 mg furosemide-equivalent diuretic use. Results Over half of the patients (56.0%) were treated with intravenous vasodilators within the first 6 hours. In this vasodilator-treated cohort, 554 (59.3%) experienced SBP reduction 25%. In patients experiencing Conclusions Intravenous vasodilator therapy was associated with greater DR and lower mortality, provided SBP reduction was less than 25%. Our results highlight the importance in early administration of intravenous vasodilators without causing excess SBP reduction in AHF management
Biodegradable core crosslinked star polymer nanoparticles as 19F MRI contrast agents for selective imaging
With the aim of developing stimuli-responsive imaging agents, we report here the synthesis of core crosslinked star (CCS) polymers and their evaluation as pH-sensitive 19F magnetic resonance imaging (19F MRI) contrast agents. Block copolymers consisting of poly(ethylene glycol)methyl ether methacrylate (PPEGMA) as the first block and a copolymer of 2-(dimethylamino)ethyl methacrylate (DMAEMA) and 2,2,2-trifluoroethyl methacrylate (TFEMA) as the second block were synthesised using RAFT polymerisation. The polymerisation kinetics were studied in detail. The block copolymers were then used as arm precursors for the arm-first synthesis of CCS polymers through RAFT dispersion polymerisation. The synthetic conditions were investigated and optimised. CCS polymers with a degradable core were also synthesised and evaluated as 19F MRI contrast agents. The degradation of the core was confirmed by treatment with various reducing agents. The particle size, 19F NMR signal and relaxation times as well as 19F MRI imaging performance of the CCS polymers were studied at a range of value of solution pH. Significant enhancement of the image intensity was observed when the pH was decreased from 8 to 5, indicating that the CCS nanoparticles could be used as 19F MRI contrast agents for the detection of the acidic environment within tumour tissue
Safer topical treatment for inflammation using 5α-tetrahydrocorticosterone in mouse models
Use of topical glucocorticoid for inflammatory skin conditions is limited by systemic and local side-effects. This investigation addressed the hypothesis that topical 5α-tetrahydrocorticosterone (5αTHB, a corticosterone metabolite) inhibits dermal inflammation without affecting processes responsible for skin thinning and impaired wound healing. The topical anti-inflammatory properties of 5αTHB were compared with those of corticosterone in C57Bl/6 male mice with irritant dermatitis induced by croton oil, whereas its effects on angiogenesis, inflammation, and collagen deposition were investigated by subcutaneous sponge implantation. 5αTHB decreased dermal swelling and total cell infiltration associated with dermatitis similarly to corticosterone after 24 h, although at a five fold higher dose, but in contrast did not have any effects after 6 h. Pre-treatment with the glucocorticoid receptor antagonist RU486 attenuated the effect of corticosterone on swelling at 24 h, but not that of 5αTHB. After 24 h 5αTHB reduced myeloperoxidase activity (representative of neutrophil infiltration) to a greater extent than corticosterone. At equipotent anti-inflammatory doses 5αTHB suppressed angiogenesis to a limited extent, unlike corticosterone which substantially decreased angiogenesis compared to vehicle. Furthermore, 5αTHB reduced only endothelial cell recruitment in sponges whereas corticosterone also inhibited smooth muscle cell recruitment and decreased transcripts of angiogenic and inflammatory genes. Strikingly, corticosterone, but not 5αTHB, reduced collagen deposition. However, both 5αTHB and corticosterone attenuated macrophage infiltration into sponges. In conclusion, 5αTHB displays the profile of a safer topical anti-inflammatory compound. With limited effects on angiogenesis and extracellular matrix, it is less likely to impair wound healing or cause skin thinning
- …